Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Other Working Capital Changes: 2016-2025

Historic Other Working Capital Changes for Akebia Therapeutics (AKBA) over the last 9 years, with Sep 2025 value amounting to -$11.6 million.

  • Akebia Therapeutics' Other Working Capital Changes fell 247.19% to -$11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year increase of 5.74%. This contributed to the annual value of -$8.9 million for FY2024, which is 24.88% up from last year.
  • As of Q3 2025, Akebia Therapeutics' Other Working Capital Changes stood at -$11.6 million, which was down 249.16% from $7.7 million recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Other Working Capital Changes registered a high of $37.1 million during Q3 2021, and its lowest value of -$11.6 million during Q3 2025.
  • Over the past 3 years, Akebia Therapeutics' median Other Working Capital Changes value was -$2.1 million (recorded in 2024), while the average stood at -$2.4 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first soared by 681.97% in 2021, then crashed by 513.73% in 2024.
  • Quarterly analysis of 5 years shows Akebia Therapeutics' Other Working Capital Changes stood at -$6.4 million in 2021, then surged by 406.10% to $19.5 million in 2022, then tumbled by 109.22% to -$1.8 million in 2023, then fell by 16.26% to -$2.1 million in 2024, then crashed by 247.19% to -$11.6 million in 2025.
  • Its Other Working Capital Changes stands at -$11.6 million for Q3 2025, versus $7.7 million for Q2 2025 and -$2.2 million for Q1 2025.